Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128850) titled 'A real-world study on the treatment of myasthenia gravis with ecuzumab' on July 27.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: The Affiliated Hospital of Xuzhou Medical University
Condition:
Generalized myasthenia gravis
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-07-31
Target Sample Size: Ecuzumab treatment group:50;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=334069
Disclaimer: Curated by HT Syndication....